Amalia Hadjimichael serves as Executive at Karyopharm Therapeutics Inc., where they oversee executive responsibilities. Since joining the company, Amalia Hadjimichael has executed 11 insider transactions totaling $13.7M, demonstrating a bearish approach to their equity position. Their most recent transaction on Dec 1, 2014 involved selling 198,115 shares valued at $8.3M.
Amalia Hadjimichael currently holds 9,132,700 shares of Karyopharm Therapeutics Inc. (KPTI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Amalia Hadjimichael has been a net seller of KPTI stock. They have purchased $0 and sold $13.7M worth of shares.
Amalia Hadjimichael's most recent insider trade was on Dec 1, 2014, when they sold 198,115 shares at $41.76 per share.
Get notified when new Form 4 filings are submitted
| $42.18 |
| Discretionary |
| Nov 26, 2014 | KPTI | $175.0K | Sale | 4,094 | $42.74 | Discretionary |
| Nov 26, 2014 | KPTI | $2.2M | Sale | 50,906 | $42.35 | Discretionary |
| Sep 12, 2014 | KPTI | $177.3K | Sale | 4,312 | $41.12 | Discretionary |
| Sep 4, 2014 | KPTI | $487.1K | Sale | 12,795 | $38.07 | Discretionary |
| Aug 25, 2014 | KPTI | $167.1K | Sale | 4,389 | $38.08 | Discretionary |
| Aug 18, 2014 | KPTI | $124.1K | Sale | 3,175 | $39.10 | Discretionary |
| Jul 29, 2014 | KPTI | $1.1M | Sale | 30,000 | $35.20 | Discretionary |
| Nov 12, 2013 | KPTI | $0 | Conversion | 10,258,079 | $N/A | Discretionary |
| Nov 12, 2013 | KPTI | $0 | Conversion | 10,258,079 | $N/A | Discretionary |